Drug client takes C&W off retainer

THE WOODLANDS, TX: Zonagen, a biotech development company trying to get a Viagra-like drug to market, has taken Cohn & Wolfe off retainer and dismissed nearly a third of its staff.

THE WOODLANDS, TX: Zonagen, a biotech development company trying to get a Viagra-like drug to market, has taken Cohn & Wolfe off retainer and dismissed nearly a third of its staff.

THE WOODLANDS, TX: Zonagen, a biotech development company trying to

get a Viagra-like drug to market, has taken Cohn & Wolfe off retainer

and dismissed nearly a third of its staff.



The company’s stock price fell last month after the FDA put a hold on

human clinical trials of Vasomax.



While Zonagen had been developing several other related drugs, the

company announced that it would shift resources to its two leading

products - Vasomax and Vasofem, a therapy for female sexual dysfunction.

It promptly laid off 15 staffers.



Zonagen’s key PR relationship is also in flux. Kathryn Metcalfe handled

the company’s corporate communications and media relations at Sciens

Worldwide, and took Zonagen with her when she moved to C&W in February.

C&W will continue working for Zonagan on a project basis.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in